脾动脉瘤的自然病史与长期随访
本单中心回顾性分析纳入2015至2019年经计算机断层扫描诊断的853例脾动脉瘤患者(共890个动脉瘤),平均随访约4年,多数动脉瘤大小稳定,仅3.2%接受干预。现有指南推荐治疗>30 mm无症状动脉瘤似属合理;但育龄女性中仅少数接受血管外科会诊和干预,提示相关推荐在普通医疗社区中可能知晓度不足。
要点
- 纳入853例患者共890个脾动脉瘤,平均诊断直径13.3±6.3 mm,平均临床随访4.1±4.0年。
- 514例有影像随访者中122例(23.7%)出现增大,仅既往吸烟与动脉瘤增大独立相关(P = .028)。
- 全队列27例(3.2%)最终接受干预,最常见指征为尺寸/增长标准(70.4%)和症状出现(18.5%)。
核心结论
- 本队列中多数脾动脉瘤大小保持稳定,在平均约4年随访期间仅少数患者需要干预。
- 鉴于其缓慢进展,现行指南推荐治疗>30 mm的无症状动脉瘤似乎是合适的。
- 尽管学会推荐所有育龄女性脾动脉瘤均应干预,但本系列中仅少数接受了血管外科会诊和干预,提示这些推荐在普通医疗社区中可能知晓度不足。
研究设计与样本
- 本研究为单机构回顾性分析,通过机构放射学数据库识别2015至2019年间经计算机断层扫描成像诊断的脾动脉瘤患者。
- 通过电子病历获取影像、人口学和临床数据,并对有放射学随访的患者计算增长率。
- 队列共853例患者、890个脾动脉瘤,其中女性692例(81.2%),育龄女性(15-50岁)37例(5.3%),诊断时平均年龄70.9岁(范围28-100岁)。
主要发现
- 常见合并症包括高血压(70.2%)、高胆固醇血症(54.7%)和既往吸烟(32.2%)。
- 影像学检查指征包括腹痛(37.3%)、无关随访(28.0%)和既往发现的內脏动脉瘤随访(8.6%)。
- 诊断时平均直径为13.3±6.3 mm;解剖位置包括脾门(36.0%)、脾动脉远端(30.3%)、脾动脉中段(23.9%)和脾动脉近端(9.7%)。
- 影像学上多数为囊状动脉瘤(72.4%)伴钙化(88.5%);1例38岁女性以25 mm动脉瘤破裂为首发诊断,立即接受血管内干预且无并发症。
- 812例患者平均临床随访4.1±4.0年,514例患者平均放射学随访3.8±6.8年;后者中122例(23.7%)出现增大。
临床怎么用
- 作者认为,鉴于脾动脉瘤缓慢进展,现行指南推荐治疗>30 mm的无症状动脉瘤似乎是合适的。
- 作者指出,尽管学会推荐所有育龄女性脾动脉瘤均应干预,但本系列中仅少数接受了血管外科会诊和干预,提示这些推荐在普通医疗社区中可能知晓度不足。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although splenic artery aneurysms (SAAs) are the most common visceral aneurysm, there is a paucity of literature on the behavior of these entities. The objective of this study was to review the natural history of patients with SAA. METHODS: This single-institution, retrospective analysis studied patients with SAA diagnosed by computed tomography imaging between 2015 and 2019, identified by our institutional radiology database. Imaging, demographic, and clinical data were obtained via the electronic medical record. The growth rate was calculated for patients with radiologic follow-up. RESULTS: The cohort consisted of 853 patients with 890 SAAs, of whom 692 were female (81.2%). There were 37 women (5.3%) of childbearing age (15-50 years). The mean age at diagnosis was 70.9 years (range: 28-100 years). Frequently observed medical comorbidities included hypertension (70.2%), hypercholesterolemia (54.7%), and prior smoking (32.2%). Imaging indications included abdominal pain (37.3%), unrelated follow-up (28.0%), and follow-up of a previously noted visceral artery aneurysm (8.6%). The mean diameter at diagnosis was 13.3 ± 6.3 mm. Anatomic locations included the splenic hilum (36.0%), distal splenic artery (30.3%), midsplenic artery (23.9%), and proximal splenic artery (9.7%). Radiographically, the majority were saccular aneurysms (72.4%) with calcifications (88.5%). One patient (38-year-old woman) was initially diagnosed at the time of rupture of a 25 mm aneurysm; this patient underwent immediate endovascular intervention with no complications. The mean clinical follow-up among 812 patients was 4.1 ± 4.0 years, and the mean radiological follow-up among 514 patients was 3.8 ± 6.8 years. Of the latter, 122 patients (23.7%) experienced growth. Aneurysm growth rates for initial sizes <10 mm (n = 123), 10 to 19 mm (n = 353), 20 to 29 mm (n = 34), and >30 mm (n = 4) were 0.166 mm/y, 0.172 mm/y, 0.383 mm/y, and 0.246 mm/y, respectively. Of the entire cohort, 27 patients (3.2%) eventually underwent intervention (81.5% endovascular), with the most common indications including size/growth criteria (70.4%) and symptom development (18.5%). On multivariate analysis, only prior tobacco use was significantly associated with aneurysm growth (P = .028). CONCLUSIONS: The majority of SAAs in this cohort remained stable in size, with few patients requiring intervention over a mean follow-up of 4 years. Current guidelines recommending treatment of asymptomatic aneurysms >30 mm appear appropriate given their slow progression. Despite societal recommendations for intervention for all SAAs among women of childbearing age, only a minority underwent vascular surgical consultation and intervention in this series, indicating that these recommendations are likely not well known in the general medical community.
引用
- Zhang J, Ratner M, Harish KB, et al. The natural history and long-term follow-up of splenic artery aneurysms. J Vasc Surg. 2023. PMID: 38081394. doi:10.1016/j.jvs.2023.11.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。